Lehigh Valley Hospital: When It Matters Most lvh.org home page Careers at LVH Education @ LVH For Professionals working with LVH
Breast Health Services

Why Mammograms Are Better at Breast Health Services

Mammography is the best way to find breast cancer early, when it is most treatable. Through an X-ray examination of the breast using extremely low radiation, mammography can detect lumps and other important changes several years before they can be felt.

Breast Health Services uses state-of-the-art equipment operated by highly trained and certified technologists. Our centers are accredited by both the Food and Drug Administration and the American College of Radiology.

Many women put off getting mammograms because they fear pain. The Woman’s Touch Mammopad ™ uses a soft foam cushion to reduce discomfort. The experience is easier, and the quality of the image is not sacrificed.

Just as important as the equipment are the physicians who read the mammograms.

Our board-certified radiologists are experts at reading mammograms. Reading more mammograms sharpens a radiologist’s skills. Each of our radiologists reads more than 1,000 mammograms each year, more than twice the FDA requirement of 480. Breast Health Services as a whole reads more than 40,000 mammograms each year.

We also use the R2 ImageChecker, which acts like a computer “spell check” for mammograms. Images are read by the radiologist in the traditional manner. Then the images are scanned by the computer, comparing them to thousands of other images. Any patterns that may be suspicious are flagged for a closer look. Research shows the ImageChecker helps radiologists detect more early stage cancers. Lehigh Valley Hospital was the first breast facility in the region to use this exciting technology.

 

This page last updated 2/12/08 04:08 PM
ARTICLE TOOLS:

email this article to a friend print this article

Click Here to Contact Breast Health Services via Relay Health

Ask Our Expert
Q: I heard the FDA recently approved a drug, Evista, to reduce the risk for breast cancer-is that true? Who can benefit from this medication?
A: Yes, in September the U.S. Food and Drug Administration (FDA) approved Evista (the brand name for raloxifene previously used to treat osteoporosis) to help prevent breast cancer in postmenopausal women who are at high-risk for the disease.

My Story
She’s No Ordinary Patient
Tammy Miller writes a book about the lighter side of breast cancer and features Aaron Bleznak, M.D., as head of her humor team.






hon cod ©2008 Lehigh Valley Hospital and Health Network
LVH Info Line: 610-402-CARE
Cedar Crest & I-78, P.O. Box 689, Allentown, PA 18105-1556

 
Increase the Size of Text by clicking here. Descrease the Size of Text by clicking here Email this story to family and friends. Print this story formatted for your printer.